Market Overview The Lysosomal Storage Disease Treatment Market is entering a period of steady expansion as advances in biotechnology, rare disease awareness, and diagnostic capabilities improve treatment options for patients with lysosomal storage disorders (LSDs). The market is anticipated to grow from approximately $4.5 billion in 2024 to $6.7 billion by 2034, representing a CAGR of around 4%...